US7611533B2
(en)
*
|
1995-06-07 |
2009-11-03 |
Cook Incorporated |
Coated implantable medical device
|
US20040023948A1
(en)
*
|
1997-03-24 |
2004-02-05 |
Green Richard David |
Fast-dispersing dosage form containing 5-HT1 agonists
|
US20030118645A1
(en)
*
|
1998-04-29 |
2003-06-26 |
Pather S. Indiran |
Pharmaceutical compositions for rectal and vaginal administration
|
US6350470B1
(en)
*
|
1998-04-29 |
2002-02-26 |
Cima Labs Inc. |
Effervescent drug delivery system for oral administration
|
US6974590B2
(en)
|
1998-03-27 |
2005-12-13 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
US20030091629A1
(en)
*
|
1998-03-27 |
2003-05-15 |
Cima Labs Inc. |
Sublingual buccal effervescent
|
US6358060B2
(en)
*
|
1998-09-03 |
2002-03-19 |
Jsr Llc |
Two-stage transmucosal medicine delivery system for symptom relief
|
US6531114B1
(en)
|
1999-04-06 |
2003-03-11 |
Wm. Wrigley Jr. Company |
Sildenafil citrate chewing gum formulations and methods of using the same
|
US6627234B1
(en)
|
1998-12-15 |
2003-09-30 |
Wm. Wrigley Jr. Company |
Method of producing active agent coated chewing gum products
|
US7163705B2
(en)
*
|
1998-12-15 |
2007-01-16 |
Wm. Wrigley Jr. Company |
Coated chewing gum product and method of making
|
US6355265B1
(en)
|
1999-04-06 |
2002-03-12 |
Wm. Wrigley Jr. Company |
Over-coated chewing gum formulations
|
US6426090B1
(en)
|
1999-04-06 |
2002-07-30 |
Wm. Wrigley Jr. Company |
Over-coated product including tableted center and medicament
|
RU2001126555A
(ru)
*
|
1999-04-06 |
2003-06-20 |
Вм. Ригли Дж. Компани (Us) |
Составы фармацевтической жевательной резинки
|
US20020159956A1
(en)
*
|
1999-04-06 |
2002-10-31 |
Ream Ronald L. |
Over-coated chewing gum formulations
|
US6773716B2
(en)
|
1999-04-06 |
2004-08-10 |
Wm. Wrigley Jr. Company |
Over-coated chewing gum formulations
|
US7935362B2
(en)
*
|
1999-04-06 |
2011-05-03 |
Wm. Wrigley Jr. Company |
Over-coated product including consumable center and medicament
|
US6645535B2
(en)
|
1999-09-02 |
2003-11-11 |
Wm. Wrigley Jr. Company |
Method of making coated chewing gum products containing various antacids
|
US6569472B1
(en)
|
2000-09-01 |
2003-05-27 |
Wm. Wrigley Jr. Company |
Coated chewing gum products containing antacid and method of making
|
US6541048B2
(en)
|
1999-09-02 |
2003-04-01 |
Wm. Wrigley Jr. Company |
Coated chewing gum products containing an acid blocker and process of preparing
|
US6663849B1
(en)
|
2000-09-01 |
2003-12-16 |
Wm. Wrigley Jr. Company |
Antacid chewing gum products coated with high viscosity materials
|
US9253991B2
(en)
|
1999-09-20 |
2016-02-09 |
Jack Barreca |
Chewing gum with B vitamins
|
US9387168B2
(en)
|
1999-09-20 |
2016-07-12 |
Jack Barreca |
Chewing gum with tomatidine
|
AU3885201A
(en)
*
|
1999-09-20 |
2001-04-24 |
Mastercare |
Diet and weight control gum and sucker
|
AU764453B2
(en)
|
1999-10-29 |
2003-08-21 |
Euro-Celtique S.A. |
Controlled release hydrocodone formulations
|
US10179130B2
(en)
|
1999-10-29 |
2019-01-15 |
Purdue Pharma L.P. |
Controlled release hydrocodone formulations
|
WO2001089476A1
(en)
*
|
2000-05-19 |
2001-11-29 |
Npd Llc |
Chewing gums, lozenges, candies, tablets, liquids, and sprays for efficient delivery of medications and dietary supplements
|
US6572900B1
(en)
|
2000-06-09 |
2003-06-03 |
Wm. Wrigley, Jr. Company |
Method for making coated chewing gum products including a high-intensity sweetener
|
US7115288B2
(en)
*
|
2000-06-09 |
2006-10-03 |
Wm. Wrigley Jr. Company |
Method for making coated chewing gum products with a coating including an aldehyde flavor and a dipeptide sweetener
|
CN101317825A
(zh)
|
2000-10-30 |
2008-12-10 |
欧罗赛铁克股份有限公司 |
控释氢可酮制剂
|
EP1347748A2
(en)
*
|
2000-12-05 |
2003-10-01 |
MacGregor, Alexander |
Hydrostatic delivery system for controlled delivery of agent
|
US7799342B2
(en)
*
|
2000-12-06 |
2010-09-21 |
Wyeth Llc |
Fast dissolving tablet
|
US6579545B2
(en)
|
2000-12-22 |
2003-06-17 |
Wm. Wrigley Jr. Company |
Coated chewing gum products containing an antigas agent
|
US7062312B2
(en)
*
|
2001-01-17 |
2006-06-13 |
Pediamed Pharmaceuticals, Inc. |
Combination and method including a visual marker for determining compliance with a medication regimen
|
US20030035839A1
(en)
*
|
2001-05-15 |
2003-02-20 |
Peirce Management, Llc |
Pharmaceutical composition for both intraoral and oral administration
|
US6613346B2
(en)
|
2001-06-28 |
2003-09-02 |
Wm. Wrigley, Jr. Company |
Chewable product including active ingredient
|
US20030017175A1
(en)
*
|
2001-07-05 |
2003-01-23 |
R.T. Alamo Ventures I, Inc. |
Sublingual administration of dihydroergotamine for the treatment of migraine
|
US20030022910A1
(en)
*
|
2001-07-05 |
2003-01-30 |
R.T. Alamo Ventures I, Inc. |
Compositions and methods for sublingual formulations of dihydroergotamine for the treatment of migraine
|
US6685951B2
(en)
|
2001-07-05 |
2004-02-03 |
R. T. Alamo Ventures I, Inc. |
Administration of dihydroergotamine as a sublingual spray or aerosol for the treatment of migraine
|
US20030198669A1
(en)
*
|
2001-07-05 |
2003-10-23 |
R.T. Alamo Ventures I, Llc |
Compositions and methods for rapid dissolving formulations of dihydroergotamine and caffeine for the treatment of migraine
|
US20030068356A1
(en)
*
|
2001-07-10 |
2003-04-10 |
Pather S. Indiran |
Sequential drug delivery systems
|
JP2005508888A
(ja)
*
|
2001-08-14 |
2005-04-07 |
バイオティ セラピーズ コーポレイション |
アルコール依存症またはアルコール中毒を治療する方法
|
US20030083286A1
(en)
*
|
2001-08-22 |
2003-05-01 |
Ching-Leou Teng |
Bioadhesive compositions and methods for enhanced intestinal drug absorption
|
US20030124196A1
(en)
*
|
2001-08-22 |
2003-07-03 |
Susan Weinbach |
Pulsatile release compositions and methods for enhanced intestinal drug absorption
|
US8603514B2
(en)
|
2002-04-11 |
2013-12-10 |
Monosol Rx, Llc |
Uniform films for rapid dissolve dosage form incorporating taste-masking compositions
|
US20190328679A1
(en)
|
2001-10-12 |
2019-10-31 |
Aquestive Therapeutics, Inc. |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US7357891B2
(en)
|
2001-10-12 |
2008-04-15 |
Monosol Rx, Llc |
Process for making an ingestible film
|
US11207805B2
(en)
|
2001-10-12 |
2021-12-28 |
Aquestive Therapeutics, Inc. |
Process for manufacturing a resulting pharmaceutical film
|
US8765167B2
(en)
|
2001-10-12 |
2014-07-01 |
Monosol Rx, Llc |
Uniform films for rapid-dissolve dosage form incorporating anti-tacking compositions
|
US10285910B2
(en)
|
2001-10-12 |
2019-05-14 |
Aquestive Therapeutics, Inc. |
Sublingual and buccal film compositions
|
US20110033542A1
(en)
|
2009-08-07 |
2011-02-10 |
Monosol Rx, Llc |
Sublingual and buccal film compositions
|
DE10224607B4
(de)
*
|
2002-06-04 |
2008-03-13 |
Lts Lohmann Therapie-Systeme Ag |
Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung
|
US20030235613A1
(en)
|
2002-06-19 |
2003-12-25 |
Cts Chemical Industries Ltd. |
Popping oral administration form
|
SI21221A
(sl)
*
|
2002-06-21 |
2003-12-31 |
LEK, tovarna farmacevtskih in kemi�nih izdelkov, d.d. |
Hitro razpadljive tablete
|
GB0217056D0
(en)
*
|
2002-07-23 |
2002-08-28 |
Ass Octel |
Use
|
US20080213363A1
(en)
*
|
2003-01-23 |
2008-09-04 |
Singh Nikhilesh N |
Methods and compositions for delivering 5-HT3 antagonists across the oral mucosa
|
BG730Y1
(bg)
*
|
2003-03-20 |
2005-04-30 |
Владимир НАЙДЕНОВ |
Ефервесцентна лекарствена форма
|
US20040191345A1
(en)
*
|
2003-03-26 |
2004-09-30 |
Fredrik Nicklasson |
New formulations and use thereof
|
US20040223921A1
(en)
*
|
2003-05-07 |
2004-11-11 |
Rau Allen H. |
Oral care tablet
|
US7306812B2
(en)
|
2003-05-09 |
2007-12-11 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US7276246B2
(en)
*
|
2003-05-09 |
2007-10-02 |
Cephalon, Inc. |
Dissolvable backing layer for use with a transmucosal delivery device
|
US7390503B1
(en)
|
2003-08-22 |
2008-06-24 |
Barr Laboratories, Inc. |
Ondansetron orally disintegrating tablets
|
US20050065175A1
(en)
*
|
2003-09-24 |
2005-03-24 |
Xanodyne Pharmacal, Inc. |
Oral transmucosal methadone
|
DE20321887U1
(de)
|
2003-11-10 |
2012-01-20 |
Allergan, Inc. |
Arzneimittel umfassend niedrige Dosierungen von Desmopressin
|
EP2322197A2
(en)
|
2003-11-10 |
2011-05-18 |
Reprise Biopharmaceutics, LLC |
Pharmaceutical compositions including low dosages of desmopressin
|
US7858121B2
(en)
*
|
2003-12-31 |
2010-12-28 |
Cima Labs, Inc. |
Effervescent oral fentanyl dosage form and methods of administering fentanyl
|
SI1708686T1
(sl)
*
|
2003-12-31 |
2011-07-29 |
Cima Labs Inc |
Splošno linearna šumeča oblika fentanila za oralno uporabo in postopek za dajanje
|
MXPA06007453A
(es)
|
2003-12-31 |
2007-01-31 |
Cima Labs Inc |
Forma de dosificacion de opiaceo oral efervescente.
|
JP2007517054A
(ja)
*
|
2003-12-31 |
2007-06-28 |
シーマ・ラブス、インコーポレイテッド |
概して線状の発泡性経口フェンタニル投薬形態および投与方法
|
US20070036853A1
(en)
*
|
2003-12-31 |
2007-02-15 |
Cima Labs Inc. |
Generally linear effervescent oral fentanyl dosage form and methods of administering
|
KR20130116378A
(ko)
*
|
2004-02-17 |
2013-10-23 |
트랜스셉트 파마슈티칼스, 인코포레이티드 |
구강 점막을 가로지르는 수면제 전달용 조성물 및 이의 사용 방법
|
GB0423800D0
(en)
|
2004-10-27 |
2004-12-01 |
Orexo Ab |
New pharmaceutical formulations
|
FR2883179B1
(fr)
*
|
2005-03-18 |
2009-04-17 |
Ethypharm Sa |
Comprime enrobe
|
US20070287740A1
(en)
*
|
2005-05-25 |
2007-12-13 |
Transcept Pharmaceuticals, Inc. |
Compositions and methods of treating middle-of-the night insomnia
|
US20070225322A1
(en)
*
|
2005-05-25 |
2007-09-27 |
Transoral Pharmaceuticals, Inc. |
Compositions and methods for treating middle-of-the night insomnia
|
JP2008542299A
(ja)
*
|
2005-05-25 |
2008-11-27 |
トランセプト・ファーマシューティカルズ・インコーポレイテッド |
真夜中不眠症の治療のための固体組成物およびその治療方法
|
US20070020186A1
(en)
*
|
2005-07-22 |
2007-01-25 |
Alpex Pharma S.A. |
Solid dosage formulations of narcotic drugs having improved buccal adsorption
|
US20070092586A1
(en)
*
|
2005-10-26 |
2007-04-26 |
Alamo Pharmaceuticals |
Compositions and methods for the administration psychotropic drugs which modulate body weight
|
US20070093471A1
(en)
*
|
2005-10-26 |
2007-04-26 |
Alamo Pharmaceuticals, Llc |
Compositions and methods for the administration clozapine formulations which modulate body weight
|
US9522188B2
(en)
*
|
2005-12-13 |
2016-12-20 |
Biodelivery Sciences International, Inc. |
Abuse resistant transmucosal drug delivery device
|
US8535714B2
(en)
|
2006-01-06 |
2013-09-17 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
US8865743B2
(en)
|
2006-01-06 |
2014-10-21 |
Acelrx Pharmaceuticals, Inc. |
Small volume oral transmucosal dosage forms containing sufentanil for treatment of pain
|
US8753308B2
(en)
|
2006-01-06 |
2014-06-17 |
Acelrx Pharmaceuticals, Inc. |
Methods for administering small volume oral transmucosal dosage forms using a dispensing device
|
US8202535B2
(en)
*
|
2006-01-06 |
2012-06-19 |
Acelrx Pharmaceuticals, Inc. |
Small-volume oral transmucosal dosage forms
|
US9289583B2
(en)
*
|
2006-01-06 |
2016-03-22 |
Acelrx Pharmaceuticals, Inc. |
Methods for administering small volume oral transmucosal dosage forms using a dispensing device
|
US9066847B2
(en)
*
|
2007-01-05 |
2015-06-30 |
Aceirx Pharmaceuticals, Inc. |
Storage and dispensing devices for administration of oral transmucosal dosage forms
|
US8252329B2
(en)
|
2007-01-05 |
2012-08-28 |
Acelrx Pharmaceuticals, Inc. |
Bioadhesive drug formulations for oral transmucosal delivery
|
US8252328B2
(en)
*
|
2006-01-06 |
2012-08-28 |
Acelrx Pharmaceuticals, Inc. |
Bioadhesive drug formulations for oral transmucosal delivery
|
US8357114B2
(en)
|
2006-01-06 |
2013-01-22 |
Acelrx Pharmaceuticals, Inc. |
Drug dispensing device with flexible push rod
|
US20070260491A1
(en)
*
|
2006-05-08 |
2007-11-08 |
Pamela Palmer |
System for delivery and monitoring of administration of controlled substances
|
US20100233257A1
(en)
*
|
2006-06-09 |
2010-09-16 |
Ethypharm |
Low dose sublingual tablets of opioid analgesics and preparation process
|
US20080069891A1
(en)
|
2006-09-15 |
2008-03-20 |
Cima Labs, Inc. |
Abuse resistant drug formulation
|
US20070299687A1
(en)
*
|
2006-06-23 |
2007-12-27 |
Pamela Palmer |
Inpatient system for patient-controlled delivery of oral transmucosal medications dosed as needed
|
MX2009000745A
(es)
*
|
2006-07-21 |
2009-04-16 |
Biodelivery Sciences Int Inc |
Dispositivos de suministro transmucosa con admision mejorada.
|
US8445018B2
(en)
|
2006-09-15 |
2013-05-21 |
Cima Labs Inc. |
Abuse resistant drug formulation
|
US20080090874A1
(en)
*
|
2006-09-20 |
2008-04-17 |
Messina John C Jr |
Treatment of breakthrough pain in patients suffering from chronic low back pain
|
WO2008067549A2
(en)
*
|
2006-11-30 |
2008-06-05 |
Transcept Pharmaceuticals, Inc. |
Stabilized zolpidem pharmaceutical compositions
|
US20090214442A1
(en)
*
|
2006-12-01 |
2009-08-27 |
Cephalon, Inc. |
Oral Transmucosal Nicotine Dosage Form
|
BRPI0719428A2
(pt)
*
|
2006-12-01 |
2014-02-25 |
Cima Labs Inc |
Forma de dosagem transmucosal oral sólida, método para tratar dependência de nicotina em um receptor que deseja tal tratamento, sistema de distribuição de nicotina transmucosal oral, e, método de substituíção de nicotina.
|
MX2009006672A
(es)
|
2006-12-19 |
2009-10-26 |
Univ Virginia |
Efectos combinados de topiramato y ondansetron sobre el consumo de alcohol.
|
JP5502494B2
(ja)
|
2007-01-22 |
2014-05-28 |
ターガセプト・インコーポレイテッド |
メタニコチンアナログの鼻腔内、バッカル、または舌下投与
|
US20080287494A1
(en)
*
|
2007-04-24 |
2008-11-20 |
Cephalon, Inc. |
Transmucosal treatment methods in patients with mucositis
|
DK2155229T3
(da)
|
2007-05-01 |
2011-05-09 |
Cephalon Inc |
Sammensætning til transmukosal indgivelse af polypeptider
|
CN102056578A
(zh)
*
|
2008-06-23 |
2011-05-11 |
生物递送科学国际公司 |
多向粘膜给药装置及使用方法
|
US8945592B2
(en)
|
2008-11-21 |
2015-02-03 |
Acelrx Pharmaceuticals, Inc. |
Sufentanil solid dosage forms comprising oxygen scavengers and methods of using the same
|
KR101004205B1
(ko)
*
|
2008-12-17 |
2010-12-24 |
동아제약주식회사 |
유데나필 함유 서방성 제제를 제조하기 위한 제어방출 조성물
|
US20130213393A1
(en)
|
2009-12-22 |
2013-08-22 |
Evoke Pharma, Inc. |
Nasal formulations of metoclopramide
|
DK3254676T3
(en)
|
2009-10-30 |
2019-03-11 |
Ix Biopharma Ltd |
QUICK-SOLVING SOLID DOSAGE FORM
|
CA2798702A1
(en)
|
2010-05-11 |
2011-11-17 |
Cima Labs Inc. |
Alcoholresistant metoprolol-containing extended-release oral dosage forms
|
AU2011274355B2
(en)
|
2010-07-02 |
2016-10-27 |
University Of Virginia Patent Foundation |
Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence
|
US9149959B2
(en)
|
2010-10-22 |
2015-10-06 |
Monosol Rx, Llc |
Manufacturing of small film strips
|
SG190448A1
(en)
|
2010-12-02 |
2013-07-31 |
Aptalis Pharmatech Inc |
Rapidly dispersing granules, orally disintegrating tablets and methods
|
WO2012087113A1
(en)
*
|
2010-12-24 |
2012-06-28 |
N.V. Nutricia |
Improved nutritional tablet
|
MX350871B
(es)
|
2011-02-28 |
2017-09-19 |
Tech Khloros Inc |
Vehiculo masticable para absorcion bucal.
|
MX2013013104A
(es)
|
2011-05-09 |
2014-10-15 |
Univ Virginia Patent Found |
Composiciones y metodos para el tratamiento de cancer.
|
SG10201610097WA
(en)
|
2011-08-18 |
2017-01-27 |
Biodelivery Sciences Int Inc |
Abuse-resistant mucoadhesive devices for delivery of buprenorphine
|
CA2848211A1
(en)
|
2011-09-09 |
2013-03-14 |
University Of Virginia Patent Foundation |
Molecular genetic approach to treatment and diagnosis of alcohol and drug dependence
|
US9901539B2
(en)
|
2011-12-21 |
2018-02-27 |
Biodelivery Sciences International, Inc. |
Transmucosal drug delivery devices for use in chronic pain relief
|
BR112014024382B1
(pt)
|
2012-04-18 |
2022-08-09 |
SpecGx LLC |
Composições farmacêuticas de contenção de abuso de liberação imediata e seu processo de preparação
|
AU2014227598B2
(en)
|
2013-03-15 |
2018-12-06 |
Braintree Laboratories, Inc. |
Dual use oral pharmaceutical composition tablets of sulfate salts and methods of use thereof
|
WO2014152296A1
(en)
|
2013-03-15 |
2014-09-25 |
Mallinckrodt Llc |
Abuse deterrent solid dosage form for immediate release with functional score
|
WO2015063602A1
(en)
|
2013-10-29 |
2015-05-07 |
Ferring B.V. |
Desmopressin and blood glucose
|
MX2016006087A
(es)
|
2013-11-11 |
2016-08-12 |
Impax Laboratories Inc |
Formulaciones de desintegracion rapida y metodos de uso.
|
AU2014331636B2
(en)
*
|
2014-02-07 |
2016-06-02 |
Sentar Pharmaceuticals, Inc. |
All natural, non-toxic sublingual drug delivery systems
|
JP6850131B2
(ja)
|
2014-07-03 |
2021-03-31 |
スペックジーエックス エルエルシー |
非セルロース多糖を含む、乱用抑止性即時放出製剤
|
US20160144528A1
(en)
|
2014-11-25 |
2016-05-26 |
Biodelivery Sciences International, Inc. |
Patch devices, methods and apparatus for forming, and testing pharmaceutical agent delivery patch devices
|
US9925138B2
(en)
|
2015-01-20 |
2018-03-27 |
Handa Pharmaceuticals, Llc |
Stable solid fingolimod dosage forms
|
GB2537652A
(en)
|
2015-04-22 |
2016-10-26 |
Cosmetic Warriors Ltd |
Composition
|
JP6523132B2
(ja)
*
|
2015-10-20 |
2019-05-29 |
リプリーズ バイオファーマシューティクス,エルエルシー |
低用量デスモプレシンを含有する医薬組成物
|
US9855227B2
(en)
|
2015-12-18 |
2018-01-02 |
The Procter & Gamble Company |
Quick dissolving diphenhydramine oral dosage form
|
US11110035B1
(en)
|
2016-02-05 |
2021-09-07 |
Gram Tactical Llc |
Tactical medicine dispensers
|
WO2017177037A1
(en)
|
2016-04-06 |
2017-10-12 |
University Of Virginia Patent Foundation |
Compositions and methods for treating cancer
|
US11273131B2
(en)
|
2016-05-05 |
2022-03-15 |
Aquestive Therapeutics, Inc. |
Pharmaceutical compositions with enhanced permeation
|
CA3022840A1
(en)
|
2016-05-05 |
2017-11-09 |
Aquestive Therapeutics, Inc. |
Enhanced delivery epinephrine compositions
|
WO2018112061A1
(en)
|
2016-12-15 |
2018-06-21 |
Evoke Pharma, Inc. |
Treatment of moderate and severe gastroparesis
|
BR112019013503A2
(pt)
|
2016-12-31 |
2020-01-07 |
Bioxcel Therapeutics, Inc. |
Uso de dexmedetomidina sublingual para o tratamento da agitação
|
US10238600B2
(en)
|
2017-04-13 |
2019-03-26 |
Richard C. Fuisz |
Package, system and methods for custody and control of drugs, and method and composition for making an oral soluble film, containing at least one active agent
|
US9901545B1
(en)
|
2017-04-13 |
2018-02-27 |
Richard C. Fuisz |
Method and composition for making an oral soluble film, containing at least one active agent
|
CN114983981A
(zh)
|
2018-06-27 |
2022-09-02 |
比奥克斯塞尔医疗股份有限公司 |
含右美托咪定的膜制剂及其制造方法
|
MX2021002459A
(es)
|
2018-09-25 |
2021-04-29 |
SpecGx LLC |
Formas de dosificacion en capsula disuasorias del abuso de liberacion inmediata.
|
CN109303334B
(zh)
*
|
2018-10-17 |
2021-04-13 |
汤臣倍健股份有限公司 |
一种口腔微泡腾片及其制备方法
|
CA3145388A1
(en)
|
2019-07-19 |
2021-01-28 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|
US11173114B1
(en)
|
2020-07-10 |
2021-11-16 |
Nova Thin Film Pharmaceuticals Llc |
Method and system for manufacturing and oral soluble films and oral soluble films made by thereby
|
US11806334B1
(en)
|
2023-01-12 |
2023-11-07 |
Bioxcel Therapeutics, Inc. |
Non-sedating dexmedetomidine treatment regimens
|